SCHEMBL7364670

SCHEMBL7364670

CNC(=O)C(=O)CCCCCCNC(=O)Nc1ccc(N(C)C)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 12/20 0.70
HDAC2 Q92769 12/20 0.70
HDAC3 O15379 11/20 0.70
HDAC4 P56524 11/20 0.70
HDAC7 Q8WUI4 11/20 0.70
HDAC10 Q969S8 11/20 0.70
HDAC11 Q96DB2 11/20 0.70
HDAC8 Q9BY41 11/20 0.70
HDAC6 Q9UBN7 11/20 0.70
HDAC9 Q9UKV0 11/20 0.70
HDAC5 Q9UQL6 11/20 0.70
CNR1 P21554 1/20 0.51
NPC1 O15118 1/20 0.48
GAA P10253 1/20 0.48
MAPT P10636 1/20 0.48
RAB9A P51151 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
LTA4H P09960 1/20 0.46
LMNA P02545 1/20 0.46
EPHX1 P07099 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7367523 0.86 ALDH1A1 (0.54) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL7368807 0.85 CNR1 (0.56) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL7373503 0.84 HDAC1 (0.70) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL7370963 0.82 L3MBTL1 (0.52) HDAC1HDAC2HDAC3HDAC4HDAC7
Hydroxyamine SCHEMBL2835145 0.82 HDAC3 (0.73) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL1367030 0.82 HDAC1 (1.00) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL7398744 0.81 ALDH1A1 (0.49) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL7373364 0.80 HDAC1 (0.60) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL7400935 0.80 CNR1 (0.50) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL7397884 0.79 HDAC1 (0.62) HDAC1HDAC2HDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020177594-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-11-28 US disclosed
WO-2002046129-A2 INHIBITORS OF HISTONE DEACETYLASE ABBOTT LABORATORIES (US) 2002-06-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020177594-A1 Inhibitors of histone deacetylase HDAC1, HDAC11, HDAC3 HDAC1 1/4885HDAC2 4/4885HDAC3 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.